Cardiac function in fetal growth restriction.


Journal

Minerva obstetrics and gynecology
ISSN: 2724-6450
Titre abrégé: Minerva Obstet Gynecol
Pays: Italy
ID NLM: 101777346

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 28 4 2021
medline: 29 10 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Fetal growth restriction (FGR) is defined as the inability of the fetus to reach its growth potential. According to the onset of the disease is defined early (<32 weeks) or late (≥32 weeks). FGR is associated with an increased risk of adverse short- and long-term outcomes, including hypoxemic events and neurodevelopmental delay compared to normally grown fetuses and increased risk of complications in the infanthood and adulthood. The underlying cause of FGR is placental insufficiency leading to chronic fetal hypoxia that affects cardiac hemodynamic with different mechanism in early and late onset growth restriction. In early onset FGR adaptive mechanisms involve the diversion of the cardiac output preferentially in favor of the brain and the heart, while abnormal arterial and venous flow manifest in the case of further worsening of fetal hypoxia. In late FGR the fetal heart shows a remodeling of its shape and function mainly related to a reduction of umbilical vein flow. In this review we discuss the modifications occurring at the level of the fetal cardiac hemodynamic in fetuses with early and late FGR.

Identifiants

pubmed: 33904691
pii: S2724-606X.21.04787-0
doi: 10.23736/S2724-606X.21.04787-0
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-434

Auteurs

Ilenia Mappa (I)

Division of Maternal and Fetal Medicine, Cristo Re Hospital, Tor Vergata University, Rome, Italy.

Pavjola Maqina (P)

Division of Maternal and Fetal Medicine, Cristo Re Hospital, Tor Vergata University, Rome, Italy.

Victoria Bitsadze (V)

Division of Maternal and Fetal Medicine, Cristo Re Hospital, Tor Vergata University, Rome, Italy.
Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Jamilya Khizroeva (J)

Division of Maternal and Fetal Medicine, Cristo Re Hospital, Tor Vergata University, Rome, Italy.
Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Alexander Makatsarya (A)

Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Domenico Arduini (D)

Department of Developmental Medicine and Prevention, Tor Vergata University, Rome, Italy.

Giuseppe Rizzo (G)

Division of Maternal and Fetal Medicine, Cristo Re Hospital, Tor Vergata University, Rome, Italy - giuseppe.rizzo@uniroma2.it.
Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH